Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy

Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy

Myotonic dystrophy type 1 (DM1) is a chronically debilitating, rare genetic disease that originates from an expansion of a noncoding CTG repeat in the dystrophia myotonica protein kinase (DMPK) gene. The expansion becomes pathogenic when DMPK transcripts contain 50 or more repetitions due to the seq...

Full description

Saved in:
Bibliographic Details
Main Authors: Estefanía Cerro-Herreros (Author), Irene González-Martínez (Author), Nerea Moreno-Cervera (Author), Sarah Overby (Author), Manuel Pérez-Alonso (Author), Beatriz Llamusí (Author), Rubén Artero (Author)
Format: Book
Published: Elsevier, 2020-09-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items